Treatment for Prostate Cancer

Posts Tagged ‘cancer’

All November, Bettes and Cantore are growing beards to raise awareness for men’s health issues and prostate cancer awareness. Al Roker, Stephanie Abrams and the participants themselves weigh-in on who has the best beard so far.

Chief of Surgery, Dr. Robert Badalament, discusses the importance for men over 50 to see a urologist at least once a year. Early detection is key in the successful treatment of prostate cancer. The three signs of detection are the PSA blood test, physical examinations, and prostate ultrasound. Patients may delay diagnosis and treatment because they’re afraid to come into urologists, but because many of the treatments are office- and medically-based, they can go home on the same day. Better Care…Better Specialists…A Better Experience The ER at Crittenton – Get Better Here™ www.Crittenton.com

Product Description
Over the last several decades epidemiological, human migratory studies, pre-clinical and even early phase clinical trials have suggested that dietary constituents may offer a protective effect in reducing the incidence of multiple cancers, including cancer of the prostate. Given the potential that some of these compounds have shown in pre-clinical and even some clinical investigations, it is essential to further identify and develop promising new agents in the hope of creating a broad spectrum of cancer chemopreventive agents. In our studies, we characterized two agents for prostate cancer chemoprevention: carnosol and alpha-mangostin. Carnosol, a dietary diterpene, found in Mediterranean herbs including basil, oregano, sage, and thyme has been shown to decrease prostate cancer cell viability. In our analysis we found carnosol to function as a dual disruptor of the androgen and estrogen receptor-alpha using in vitro and in vivo models. Further study found these traits to be unique when compared to FDA approved anti-androgens and anti-estrogens. alpha-Mangostin, a dietary xanthone, isolated from the mangosteen fruit, was also observed to decrease prostate cancer cell viability. We evaluated alpha-mangostin for kinase inhibition against 50 different kinases. Of those, alpha-mangostin was found to be most effective against CDK4. Our analysis describes the in vitro and in vivo inhibition of prostate cancer using alpha-mangostin. We are proposing that alpha-mangostin and carnosol have unique mechanisms of action and may be further developed as cancer chemopreventive agents.

Selected plant constituents for the prevention and treatment of prostate cancer.

Dr. Rajesh N. Mehra’s interviews with 3 different Urologists in the Washington DC Metro Area regarding treatment of prostate cancer using modern therapy regimens. The urologists are: Dr. Glover, Dr. Bilowus, & Dr. Guleria. These interviews aired on Salaam India, which is a production of Global Television Network. Salaam India airs weekly on MHz Networks and the Executive Producer is Dr. Rajesh N. Mehra, DO of Chantilly Family Practice Center (www.ChantillyMedicalPractice.com). Global TV Network also produces Chitrmala, also seen on MHz Networks. Please see our Youtube channel for more interviews and video clips as well as our website, www.ThisisGTV.com, and also check out Chitrmala’s page on Facebook! This material is copyrighted and is the property of Global Television Networks, Inc. Any unauthorized use or reproduction of this material is strictly prohibited.

Patient testimonial on treatment of Prostate Cancer at the CyberKnife Centers of San Diego, Southern California’s leaders in CyberKnife treatment. Visit us at www.sdcyberknife.com

Product Description

How We Survived Prostate Cancer: What We Did and What We Should Have Done

Product Description
The facts every man needs to know, as well as testimonials of hope and inspiration from over 50 well known survivors of prostate cancer.

The ABC’s of Prostate Cancer

The Calypso targeting system provides a new level of precision in the treatment of prostate cancer. Working like GPS for the prostate, the Calypso system uses three tiny beacons placed in the prostate gland to triangulate and guide the radiation system to hit only the prostate with cancer-killing radiation and sparing the surrounding healthy areas. The Nebraska Medical Center was one of just five American hospitals that took part in the original clinical trials for Calypso. “I am extremely excited to be able to offer men radiation therapy using Calypso. Out of all the radiation targeting therapies used to treat cancer today, the Calypso system is the most advanced and the most accurate,” said Charles Enke, MD, radiation oncologist at The Nebraska Medical Center and chairman of the Department of Radiation Oncology at the University of Nebraska Medical Center. Dr. Enke said Calypso is also the only system that doesn’t require human interpretation to pinpoint the tumor target. Instead, tiny electromagnetic sensors about the size of a grain of rice are implanted in the patient’s prostate before treatment. Then, during the entire treatment, the sensors continuously transmit information back to Calypso, 10 times per second, regarding the position and motion of the prostate. “We knew the prostate moved during radiation treatment, but we were surprised to learn from the pre-FDA approval study just how much, and how often it moves,” Dr. Enke said. To account for that motion …

One of every six American men can expect to be diagnosed with prostate cancer. If you’re 40 or older, get screened now

Product Description
Treatment strategies in prostate cancer underlie a permanent change due to continuous improvements. Based on the 10th International Symposium on Special Aspects of Radiotherapy held in Berlin in 2006, this volume highlights key advances in surgical, radiooncological and systemic treatment standards for prostate cancer. Furthermore, interdisciplinary co-operations and controversies are presented and future developments are discussed. The four parts of the book cover the different stages of the disease – localized prostate cancer, the lymph node positive situation, biochemical recurrence, and hormone-refractory and metastatic prostate cancer. Special attention is given to the value and sequence of systemic treatment options in relation to surgery and radiotherapy. Proving the reader with the latest treatment standards of prostate cancer, this book will be of great value to urologists and radiation oncologists as well as to all others involved in the care of patients with prostate cancer.

Controversies in the Treatment of Prostate Cancer: 10th International Symposium on Special Aspects of Radiotherapy, Berlin, September 2006